This title appears in the Scientific Report :
2019
Please use the identifier:
http://hdl.handle.net/2128/21726 in citations.
Please use the identifier: http://dx.doi.org/10.1016/j.cllc.2018.10.011 in citations.
Monitoring treatment response to Erlotinib in EGFR-mutated nonesmall-cell lung cancer brain metastases using serial O-(2-[18F]fluoroethyl)-L-tyrosine PET
Monitoring treatment response to Erlotinib in EGFR-mutated nonesmall-cell lung cancer brain metastases using serial O-(2-[18F]fluoroethyl)-L-tyrosine PET
Saved in:
Personal Name(s): | Abdulla, D. S. Y. |
---|---|
Scheffler, M. / Brandes, V. / Ruge, M. / Kunze, S. / Merkelbach-Bruse, S. / Nogova, L. / Michels, S. / Fischer, R. / Riedel, R. / Büttner, R. / Persigehl, T. / Grau, S. / Galldiks, N. / Drzezga, A. / Kobe, C. / Wolf, J. (Corresponding author) | |
Contributing Institute: |
Molekulare Organisation des Gehirns; INM-2 Kognitive Neurowissenschaften; INM-3 |
Published in: | Clinical lung cancer, 20 (2019) 2, S. e148-e151 |
Imprint: |
Dallas, Tex.
Cancer Information Group
2019
|
PubMed ID: |
30528316 |
DOI: |
10.1016/j.cllc.2018.10.011 |
Document Type: |
Journal Article |
Research Program: |
(Dys-)function and Plasticity |
Link: |
OpenAccess OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1016/j.cllc.2018.10.011 in citations.
Description not available. |